Diagnostic utility of high-risk human papillomavirus mRNA in situ hybridisation in squamous cell carcinoma of unknown primary in the head and neck and implementing American Society of Clinical Oncology guideline recommendations.,Cytopathology

当前位置： X-MOL 学术 › Cytopathology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Diagnostic utility of high-risk human papillomavirus mRNA in situ hybridisation in squamous cell carcinoma of unknown primary in the head and neck and implementing American Society of Clinical Oncology guideline recommendations.
Cytopathology ( IF 1.2 ) Pub Date : 2020-07-31 , DOI: 10.1111/cyt.12896
Parnaz Daneshpajouhnejad ₁ , James Adam Miller ₂ , Zahra Maleki ₁

Affiliation

The American Society of Clinical Oncology (ASCO)‐endorsed College of American Pathologists guideline recommends high‐risk human papillomavirus (HPV) testing for metastatic squamous cell carcinoma (SCC) of lymph nodes level II/III of unknown primary. Herein, the performance of HPV‐RNA in situ hybridisation (ISH) in detection of HPV‐related SCC is evaluated implementing the ASCO guideline recommendations.

中文翻译：

高危人乳头瘤病毒 mRNA 原位杂交在头颈部不明原发鳞状细胞癌中的诊断效用，并实施美国临床肿瘤学会指南建议。

美国临床肿瘤学会 (ASCO) 认可的美国病理学家学院指南建议对未知原发灶的 II/III 级淋巴结转移性鳞状细胞癌 (SCC) 进行高危人乳头瘤病毒 (HPV) 检测。在此，HPV-RNA 原位杂交 (ISH) 在检测 HPV 相关 SCC 中的性能根据 ASCO 指南建议进行评估。

更新日期：2020-07-31

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11